Jacqualyn A. Fouse
2019 - Agios Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $424,125 |
---|---|
Option Awards | $12,875,608 |
Salary | $664,583 |
Stock Awards | $2,538,474 |
Other | $105,204 |
Total | $16,607,994 |
Fouse received $12.9M in option awards, accounting for 78% of the total pay in 2019.
Fouse also received $424.1K in non-equity incentive plan, $664.6K in salary, $2.5M in stock awards and $105.2K in other compensation.
Rankings
In 2019, Jacqualyn A. Fouse's compensation ranked 273rd out of 13,971 executives tracked by ExecPay. In other words, Fouse earned more than 98.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 273 | 98th |
Manufacturing | 96 | 98th |
Chemicals And Allied Products | 25 | 99th |
Drugs | 21 | 99th |
Pharmaceutical Preparations | 18 | 99th |
Pay ratio
Jacqualyn A. Fouse's Pay | $16,607,994 |
---|---|
Median Employee's Pay | $267,104 |
Pay Ratio | 62to 1 |
In 2019, the annual total compensation of Jacqualyn A. Fouse was $16,607,994.
The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.
The ratio of Jacqualyn A. Fouse's pay to the pay of median employee was therefore 62 to one.
Fouse's colleagues
We found five more compensation records of executives who worked with Jacqualyn A. Fouse at Agios Pharmaceuticals in 2019.
2019
Andrew Hirsch
Agios Pharmaceuticals
Chief Financial Officer
2019
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
2019
Scott Biller
Agios Pharmaceuticals
Chief Scientific Officer
2019
Jonathan Biller
Agios Pharmaceuticals
Chief Legal Officer
2019
David Schenkein
Agios Pharmaceuticals